20MICRONS 20 Microns Q4 FY25 results (Jan–Mar 2025) and concall
20 Microns delivered a robust performance in Q4 and full year FY25, achieving ₹912.7 crores in annual revenue, marking a 17.4% YoY growth. The company demonstrated improved profitability with Q4 EBITDA margins at 12.7% and maintained FY25 EBITDA margins at 12.8% amidst market and geopolitical challenges. Strategic initiatives included a Malaysian acquisition, significant CapEx in the Nano subsidiary, and a continued focus on value-added products, while managing increased working capital requirements driven by strategic inventory build-up for imported raw materials.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 |
|---|---|---|---|
| Revenue | 210 | 186 | 198 |
| EBITDA | 26 | 22 | 25 |
| Net profit | 15 | 10 | 15 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
